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Rezumat
Colita ulceroasă şi infecţia cu citomegalovirus
Boala infl amatorie intestinală (BII) este numele generic 
a două entităţi: boala Crohn şi colita ulceroasă care 
reprezintă o inflamaţie cronică nespecifică a tractului 
gastrointestinal. Infecţia cu citomegalovirus (CMV) este 
o infecţie virală comună la om. Ea determină de multe ori
infecţie primară şi ulterior persistă pe tot parcursul vieţii 
într-un stadiu latent. În diverse situaţii de imunosupresie, 
virusul se poate reactiva şi cauza boli, afectând multiple 
organe, inclusiv tractul gastrointestinal. Etiologia BII nu 
este clară şi infecţia CMV este deseori asociată cu BII. În 
acest articol este analizată legătura patogenetică dintre 
BII şi infecţia CMV. 
Cuvinte-cheie: boală inflamatorie intestinală, colită 
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Резюме
Язвенный колит и цитомегаловирусная инфекция
Воспалительные заболевания кишечника (ВЗК) – это 
общее название хронических неспецифических по-
ражений кишечника, которые включают язвенный 
колит и болезнь Крона. Цитомегаловирусная (ЦМВ) 
инфекция, с другой стороны, представляет собой 
распространенное вирусное заболевание, которое за-
частую обуславливает первичную инфекцию и затем 
персистирует в организме в неактивной форме. При 
развитии иммуносупресии, вирусная инфекция может 
активироваться и вызывать различные патологии, 
включая поражение желудочно-кишечного тракта. 
Этиология ВЗК неизвестна, однако отмечена частая 
ассоциация ВЗК с ЦМВ инфекцией. В данном обзоре 
литературы обсуждаются возможные патогенети-
ческие связи между ВЗК и ЦМВ.
Ключевые слова: воспалительные заболевания кишеч-
ника, язвенный колит, болезнь Крона, цитомегалови-
русная инфекция
Introduction
Inflammatory bowel disease (IBD) represents 
chronic non-specific inflammation of gastrointesti-
nal tract. The etiology of IBD is not clear and Cyto-
megalovirus infection is often associated with IBD. 
Early studies indicated that CMV infection can lead 
to subsequent development of IBD [1]. This may be 
possible in some susceptible patients but in the most 
recent reports CMV colitis occurred primarily in pa-
tients with pre-existing IBD [2, 3]. The pathogenetic 
link between IBD and CMV infection was supposed 
and began to be studied in the last decades. 
The aim of the study was to evaluate critically 
literature data on the relationship between CMV 
and IBD.
Methods
Internet search was conducted in Medline (from 
1966 to 2013) and PubMed (from 1980 to 2013) data-
base using words “cytomegalovirus”, “inflammatory 
bowel disease”, “ulcerative colitis”, “Crohn’s disease”. 
Results and discussion
419 articles were found. The prevalence of CMV 
infection is high, ranging from 30–100%, depending 
on age and race. Cytomegalovirus is a member of the 
Herpesviridae family which contains a double-stran-
ded DNA. Most CMV infections are acquired either 
in the perinatal period and infancy or in adulthood 
through sexual contact [4]. It often causes primary 
infection in humans, and later persists lifelong in 
a latent stage. Primary infection in the immuno-
competent hosts is usually asymptomatic or causes 
syndrome with fever, myalgia and pharyngitis. Gas-
trointestinal affectation due to primary infection 
has been described but is rare, and manifests with 
bloody diarrhea, tenesmus, abdominal pain, fever, 
anorexia, malaise and weight loss [3]. CMV can 
cause esophagitis, gastritis, ulcers, terminal ileitis 
and colitis.
In latent infection principal reservoirs of CMV 
are fibroblasts, myeloid cells and endothelial cells 
[5]. Peripheral blood monocytes constitute a major 
site of viral latency and may be triggered by secreted 
proinflammatory cytokines and chemokines. They 
can differentiate into tissue macrophages, leading 
to CMV reactivation and probably to CMV disease. 
Endothelial cells are also a common target for CMV 
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in vivo, regardless of the organ involved. The vascu-
lar endothelium represents the interface between 
circulating immune cells and the lamina propria of 
the gut and this can partially explain the role of CMV 
in cases of intestinal inflammation.
The association between CMV and IBD was 
described long ago. The first case report dates from 
1961, when Powell and coauthors described a pa-
tient with UC and “cytomegalic inclusion” disease. 
Since then, questions about the role of CMV in these 
patients remains open [7]. Does CMV reactivation 
exacerbate the disease in patients with pre-existing 
IBD or is reactivation a consequence of IBD activity 
and its treatment with CMV acting as an innocent 
bystander [3, 8]? Interpretation of existing results is 
limited because most studies are small and retros-
pective, with different diagnostic methods of CMV 
detection and even different classifications of the 
severity of concomitant IBD.
Patients with IBD are immunosuppressed due 
to chronic inflammation, medications and poor nu-
trition [2, 9]. CMV reactivation may be triggered by 
TNF-ά, catecholamines and proinflammatory pros-
taglandins [10]. During active IBD, local expression 
of a wide variety of cytokines including TNF-a, IFN-γ, 
and IL-2 is induced, with activation of transcription 
factors (NF-Kb) and production of chemokines and 
adhesion molecules that recruit circulating monocy-
tes and dendritic cells in the area of inflammation. 
There, these cells differentiate into permissive cells 
supporting active replication of the virus. Endothelial 
cells can also serve as permissive cells as they have 
been shown to stimulate T-cells to produce IL-2 and 
to proliferate. Activated T-cells consequently produ-
ce TNF-ά and IFN-γ and perpetuate the inflammation 
process causing more injury to the gut. These indi-
cate that CMV has tropism for sites of inflammation 
and confirm the results of clinical studies that have 
shown presence of CMV in the affected region of the 
gut  in the IBD patients. They also indicate that CMV 
replication is the result of CMV reactivation rather 
than primary infection.
Experimental studies have identified three fac-
tors that influence the reactivation of CMV infection 
in active colitis:
• increased cell proliferation in inflamed tissue
with ulcers that attract CMV;
• inherent impaired natural killer cell activity
presented by patients with IBD;
• use of immunosuppressive drug [6].
The third factor is controversial, since use of 
steroids may be either a risk factor or a surrogate 
marker of severity disease [2, 9]. In vitro data suggest 
that steroids and cyclosporine could support the 
replication of CMV [11]. Recent studies suggested 
CMV can appear only in inflamed tissue and is not 
found in healthy tissue.
Hommes and coauthors proposed the fol-
lowing sequence to explain the pathophysiology of 
CMV disease in patients with active UC: 
• initiation phase, mucosal inflammatory respon-
se induces expression of cytokines and chemo-
kines which activates latently infected cells and 
the migration of monocytes and dendritic cells 
into the inflamed mucosa;
• reactivation phase, in which infected monocy-
tes differentiate into tissue macrophages and 
dendritic cells; 
• consolidation phase, during which the virus
causes an active replication predominantly in 
endothelial cells that likely exacerbates inflam-
mation [10].
Theoretically, all latently infected IBD patients 
receiving immunosuppressive treatment frequently 
produce infectious virus and don’t allow antiviral 
immune responses to develop. In two recent clinical 
studies, corticosteroids did not seem to be a major 
factor in the development of CMV infection and 
disease in IBD patients [12, 13].
There have also been reports of colitis patients 
with evidence of active CMV infection who improved 
with steroids and did not require antiviral treatment 
[14], as well as patients with active colonic CMV in-
fection without active colitis [15]. In these cases CMV 
seems to behave like an innocent bystander. As it has 
been mentioned before, CMV has the propensity to 
infect rapidly growing tissue, especially endothelial 
cells in granulation tissue. Some studies suggested 
that CMV represents an opportunistic infection in 
severely inflamed mucosa rather than a primary 
pathogen [16].
The most widely held theory is that CMV infects 
areas of active IBD and causes further tissue injury 
aggravating the severity of the underlying IBD. In 
the majority of case-reports patients with severe 
attacks of IBD and CMV infection had significant 
morbidity (toxic megacolon 15%, colectomy up to 
62%) and mortality (up to 44%). Antiviral treatment 
prevented colectomy in some but not all of the 
patients. In more recent series the mortality rate of 
CMV colitis in UC were 30% and the rate of surgery 
40% [9]. CMV disease seems to be less frequent in 
patients with Crohn’s disease compared to patients 
with ulcerative colitis.
Conclusion
The role of CMV infection in patients with IBD 
has not yet been clearly defined. In the majority of 
published studies CMV is considered to act like a true 
pathogen, complicating the course of IBD, causing 
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the resistance while in the others, CMV does not 
seem to alter the natural course of the underlying 
IBD. Further prospective studies are needed to clarify 
the role of CMV infection 
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